Global X HealthTech ETF (NASDAQ:HEAL – Get Free Report) was the recipient of a large decline in short interest during the month of August. As of August 31st, there was short interest totaling 5,796 shares, a decline of 62.7% from the August 15th total of 15,534 shares. Based on an average trading volume of 14,071 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.5% of the company’s shares are short sold.
Hedge Funds Weigh In On Global X HealthTech ETF
A number of hedge funds have recently bought and sold shares of HEAL. Glenmede Investment Management LP acquired a new stake in Global X HealthTech ETF during the third quarter worth approximately $31,000. Banque Cantonale Vaudoise bought a new position in shares of Global X HealthTech ETF during the 3rd quarter worth approximately $37,000. Royal Bank of Canada grew its position in shares of Global X HealthTech ETF by 39.4% during the 1st quarter. Royal Bank of Canada now owns 2,603 shares of the company’s stock worth $62,000 after buying an additional 736 shares during the period. EverSource Wealth Advisors LLC grew its position in shares of Global X HealthTech ETF by 26,522.2% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,396 shares of the company’s stock worth $70,000 after buying an additional 2,387 shares during the period. Finally, Citadel Advisors LLC bought a new stake in shares of Global X HealthTech ETF in the 3rd quarter valued at $216,000.
Global X HealthTech ETF Price Performance
NASDAQ HEAL traded up $0.18 on Friday, reaching $28.48. The company had a trading volume of 2,756 shares, compared to its average volume of 10,499. The business has a 50 day moving average of $28.54 and a two-hundred day moving average of $26.51. Global X HealthTech ETF has a fifty-two week low of $23.00 and a fifty-two week high of $33.59. The firm has a market cap of $30.18 million, a price-to-earnings ratio of 42.80 and a beta of 1.11.
About Global X HealthTech ETF
An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.
Featured Stories
- Five stocks we like better than Global X HealthTech ETF
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
- Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
- As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits
Receive News & Ratings for Global X HealthTech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X HealthTech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
